Medical Marijuana Inc.'s HempMedsPX Continues Mission in Support of Non-Profit Organizations, Announces Support of CDKL5 Epilepsy and Seizure Research
Wednesday, Oct 30, 2013

SAN DIEGO, Oct. 30, 2013 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMedsPX™ — a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc. — that HempMedsPX™ recently presented a donation to augment the non-profit organization Hope4Harper's mission to fund CDKL5 epilepsy and seizure research through Dr. Frances Jensen, Chair of the Department of Neurology at the University of Pennsylvania. "We are honored to support medical research focused on easing the suffering of people with debilitating ailments," states Michelle Sides, COO of Medical Marijuana, Inc.

HempMedsPX(TM) VP of Communications, Charles Vest, with Supporting CDKL5 Disorder & Seizure Research

A photo accompanying this release is available at

With no known cure, CDKL5 is a rare genetic seizure disorder that typically presents itself in the first few months of a child's life. Many with CDKL5 are not able to talk, walk, feed themselves, are confined to a wheelchair and suffer from an array of health issues. Penny Howard founded Hope4Harper for her daughter, Harper, who was diagnosed with CDKL5 at the age of ten months. While Penny and her husband are open to all mediums of therapy for three-year-old Harper, the Howards decided to add Real Scientific Hemp Oil™ (RSHO™) to Harper's daily routine and is sharing her results on a weekly blog at

for people of all ages for animals legally in all 50 states and in more than 40 countries through dispensary and non-dispensary outlets